How breast cancer research is helping prostate cancer patients

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Cure Today

First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...
Nasdaq

Cortechs.ai and EDAP TMS SA Announce Successful First OnQ Prostate-Assisted Focal One® HIFU Procedure at UCSF Prostate Cancer Center

The first OnQ Prostate-assisted Focal One® Robotic HIFU procedure was successfully performed at UCSF, improving prostate cancer treatment precision. Cortechs.ai and EDAP TMS have announced the ...

First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate ...

The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...